Home / Drug shortages / Clindamycin Phosphate; Benzoyl Peroxide Gel

Clindamycin Phosphate; Benzoyl Peroxide Gel — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Clindamycin Phosphate; Benzoyl Peroxide Gel (gel) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 08/01/2025.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0591-3916-68
Dosage Form
Gel
Presentation
Clindamycin Phosphate; Benzoyl Peroxide, Gel, 25 mg/1 g; 10 mg/1 g (NDC 0591-3916-68)
Initial Posting
08/01/2025
Revised Date

FDA data resources